0001209191-18-041906.txt : 20180706 0001209191-18-041906.hdr.sgml : 20180706 20180706180632 ACCESSION NUMBER: 0001209191-18-041906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180703 FILED AS OF DATE: 20180706 DATE AS OF CHANGE: 20180706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLATTERY JOSEPH P CENTRAL INDEX KEY: 0001246530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 18943123 MAIL ADDRESS: STREET 1: C/O TRANSENTERIX, INC. STREET 2: 635 DAVIS DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-03 0 0000876378 TRANSENTERIX INC. TRXC 0001246530 SLATTERY JOSEPH P C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 0 1 0 0 EVP and CFO Common Stock 2018-07-03 4 M 0 166667 0.00 A 166667 D Common Stock 2018-07-03 4 F 0 58334 3.84 D 108333 D Common Stock 2018-07-03 4 S 0 2491 4.01 D 105842 D Common Stock 2018-07-03 4 S 0 11883 4.00 D 93959 D Common Stock 2018-07-05 4 S 0 37337 4.00 D 56622 D Common Stock 25000 I By IRA Restricted Stock Units 2018-07-03 4 M 0 166667 0.00 D Common Stock 166667 333333 D This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. The transaction occurred pursuant to a written trading plan dated November 29, 2017, meeting the requirements of Rule 10b5-1(c). Following the sales on July 3, 2018 and July 5, 2018, the reporting person continues to beneficially own 81,622 shares of the company's common stock. The reporting person also holds stock options to acquire 1,886,821 shares of common stock, of which approximately 27% are vested, and restricted stock units representing an additional 595,777 shares of common stock subject to forfeiture restrictions. Each restricted stock unit represents the right to receive one share of the Registrant's common stock. Forfeiture restrictions will lapse as to 1/3rd of the Restricted Stock Units on each of the first three anniversaries of the date of grant, as long as the Reporting Person remains in the employ of the Registrant. The lapse of forfeiture restrictions may accelerate on certain events as set forth in an employment agreement or the Incentive Plan. /s/ Joshusa Weingard, as Attorney-in-Fact for Joseph Slattery 2018-07-06